Ruogu Qi

3.1k total citations
59 papers, 2.7k citations indexed

About

Ruogu Qi is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Ruogu Qi has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 27 papers in Biomaterials and 15 papers in Oncology. Recurrent topics in Ruogu Qi's work include Nanoparticle-Based Drug Delivery (25 papers), Advanced biosensing and bioanalysis techniques (13 papers) and RNA Interference and Gene Delivery (12 papers). Ruogu Qi is often cited by papers focused on Nanoparticle-Based Drug Delivery (25 papers), Advanced biosensing and bioanalysis techniques (13 papers) and RNA Interference and Gene Delivery (12 papers). Ruogu Qi collaborates with scholars based in China, United States and Malawi. Ruogu Qi's co-authors include Xiabin Jing, Haihua Xiao, Yubin Huang, Lesan Yan, Shi Liu, Haiqin Song, Wenliang Li, Yonghui Zheng, Zhigang Xie and Xuesi Chen and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Nature Communications.

In The Last Decade

Ruogu Qi

58 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruogu Qi China 29 1.1k 1.1k 1.0k 637 422 59 2.7k
Daria Y. Alakhova United States 12 1.4k 1.3× 1.3k 1.2× 810 0.8× 366 0.6× 367 0.9× 20 2.9k
Peisheng Xu United States 32 1.3k 1.2× 1.3k 1.2× 1.2k 1.1× 440 0.7× 235 0.6× 63 3.3k
Ying Piao China 26 1.4k 1.3× 1.3k 1.2× 1.7k 1.7× 504 0.8× 278 0.7× 61 3.1k
Xuanrong Sun China 22 1.2k 1.1× 1.1k 1.0× 1.3k 1.3× 600 0.9× 292 0.7× 57 2.7k
Wanyi Tai United States 23 847 0.8× 1.8k 1.6× 926 0.9× 307 0.5× 427 1.0× 47 3.0k
Yinan Zhong China 25 1.4k 1.3× 1.0k 0.9× 1.3k 1.3× 374 0.6× 226 0.5× 60 2.5k
Qixian Chen China 34 984 0.9× 1.4k 1.3× 1.2k 1.2× 771 1.2× 162 0.4× 115 3.2k
Jiajia Xiang China 27 1.4k 1.3× 1.3k 1.2× 1.7k 1.7× 493 0.8× 255 0.6× 75 3.1k
Wangwen Gu China 28 1.5k 1.3× 1.4k 1.3× 1.4k 1.4× 318 0.5× 272 0.6× 39 2.9k
Yanzuo Chen China 27 1.6k 1.5× 1.2k 1.1× 1.1k 1.0× 318 0.5× 322 0.8× 42 2.9k

Countries citing papers authored by Ruogu Qi

Since Specialization
Citations

This map shows the geographic impact of Ruogu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruogu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruogu Qi more than expected).

Fields of papers citing papers by Ruogu Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruogu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruogu Qi. The network helps show where Ruogu Qi may publish in the future.

Co-authorship network of co-authors of Ruogu Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruogu Qi. A scholar is included among the top collaborators of Ruogu Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruogu Qi. Ruogu Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shanshan, et al.. (2025). Intervening Non-Small-Cell Lung Cancer Progression by Cell Membrane Coated Platycodin D via Regulating Hsa-miR-1246/FUT9/GSK3β Pathway. International Journal of Nanomedicine. Volume 20. 1661–1678. 2 indexed citations
2.
Wang, Zian, et al.. (2024). Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine. International Journal of Nanomedicine. Volume 19. 2507–2528. 11 indexed citations
3.
Zhou, Yitian, Jun Li, Qiang Zhang, et al.. (2024). Targeted regulation of autophagy using sorafenib-loaded biomineralization nanoenzyme for enhanced photodynamic therapy of hepatoma. Materials Today Bio. 29. 101270–101270. 2 indexed citations
4.
Liu, Zixian, et al.. (2024). Unraveling the immune landscape and therapeutic biomarker PMEPA1 for oxaliplatin resistance in colorectal cancer: A comprehensive approach. Biochemical Pharmacology. 222. 116117–116117. 3 indexed citations
6.
Wang, Xuan, et al.. (2023). Nano‐omics: Frontier fields of fusion of nanotechnology. SHILAP Revista de lepidopterología. 2(4). e20230039–e20230039. 6 indexed citations
7.
Wang, Shanshan, et al.. (2023). Platycodin D inhibits angiogenic vascular mimicry in NSCLC by regulating the eIF4E-mediated RNA methylome. Journal of Pharmaceutical Analysis. 14(1). 152–155.
8.
Guo, Yuanyuan, et al.. (2023). Chances and challenges in intranasal administration delivery for brain disease treatment. SHILAP Revista de lepidopterología. 3(6). 11 indexed citations
9.
Niu, Qiang, Yu Liu, Yujing Zheng, et al.. (2022). Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics. Acta Pharmaceutica Sinica B. 12(12). 4458–4471. 31 indexed citations
11.
Zhu, Guixian, Lin Cheng, Ruogu Qi, et al.. (2019). A metal-organic zeolitic framework with immobilized urease for use in a tapered optical fiber urea biosensor. Microchimica Acta. 187(1). 72–72. 46 indexed citations
12.
Yang, Xi, Yingjie Yu, Xing Huang, et al.. (2018). Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance. Materials Science and Engineering C. 96. 96–104. 47 indexed citations
13.
Qi, Ruogu, Yongheng Wang, Peter M. Bruno, et al.. (2017). Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer. Nature Communications. 8(1). 2166–2166. 70 indexed citations
14.
Tao, Zhimin, Xiangnan Dang, Xing Huang, et al.. (2017). Early tumor detection afforded by in vivo imaging of near-infrared II fluorescence. Biomaterials. 134. 202–215. 101 indexed citations
15.
Chen, Qixian, Ruogu Qi, Xiyi Chen, et al.. (2017). A Targeted and Stable Polymeric Nanoformulation Enhances Systemic Delivery of mRNA to Tumors. Molecular Therapy. 25(1). 92–101. 79 indexed citations
16.
Xiao, Haihua, Haiqin Song, Yu Zhang, et al.. (2012). The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy. Biomaterials. 33(33). 8657–8669. 76 indexed citations
17.
Xiao, Haihua, Lesan Yan, Yu Zhang, et al.. (2012). A dual-targeting hybrid platinum(iv) prodrug for enhancing efficacy. Chemical Communications. 48(87). 10730–10730. 67 indexed citations
18.
Yan, Lesan, Jianxun Ding, Ruogu Qi, et al.. (2011). Versatile synthesis of functional biodegradable polymers by ring-opening polymerization and microwave-assisted click reaction. Journal of Controlled Release. 152. e249–e250. 3 indexed citations
19.
Dong, Xiaoqing, Ruogu Qi, Yubin Huang, & Xiabin Jing. (2011). Synthesis of biodegradable dextran-g-(PCL-b-PEG) by combination of ring-opening polymerization and click chemistry. Journal of Controlled Release. 152. e198–e199. 6 indexed citations
20.
Xiao, Haihua, Ruogu Qi, Shi Liu, et al.. (2011). Biodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II). Biomaterials. 32(30). 7732–7739. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026